Literature DB >> 11750277

Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis.

Jan Gewaltig1, Kerstin Mangasser-Stephan, Carsten Gartung, Stefan Biesterfeld, Axel M Gressner.   

Abstract

BACKGROUND: The objective of the present study was to elucidate possible relationships between four polymorphisms of the TGF-beta1 gene (-800G>A; -509C>T; Leu10Pro; Arg25Pro) and stage, histological activity grade and progression rate of liver fibrosis, classified according to the METAVIR-score.
METHODS: Three study groups, i.e. 48 patients with hepatic fibrosis (26 with known duration of hepatitis C virus infection), 47 patients with non-fibrotic diseases and 50 healthy blood donors, were analyzed for TGF-beta1 polymorphisms using ARMS-PCR and sequence analysis. The concentrations of total TGF-beta1 in plasma and of hyaluronan, P-III-NP and activities of transminases in serum were measured.
RESULTS: The presence of proline at codons 10 and/or 25 was associated with a faster progression of fibrosis than other polymorphisms. Patients with the genotype (25)ArgPro developed fibrosis significantly faster (0.23 units/year) than those having (25)ArgArg (0.08 units/year). Similarly, the fibrosis progression rate of patients with genotypes (10)LeuPro and (10)ProPro was almost three times as fast as of those having genotype (10)LeuLeu. Stage and histological activity grade of fibrosis in (25)ArgPro in comparison to (25)ArgArg were higher. Also (10)LeuPro showed a higher average stage of fibrosis than (10)LeuLeu. The TGF-beta1 plasma concentrations of patients with hepatic fibrosis were not significantly different between carriers of (25)ArgArg and (25)ArgPro genotypes. The frequency of the genotype (25)ArgPro in liver fibrotic patients was about three times that of the control group whereas the frequency distribution of the genotype (25)ArgArg tended to lower frequency in the fibrosis group. TGF-beta1-promoter polymorphisms did not show any correlation with stage, grade or progression of liver fibrosis.
CONCLUSION: Our results indicate that the heterozygous ArgPro of codon 25 predicts significantly faster fibrotic progression of chronic hepatitis C than the homozygous (25)ArgArg genotype. The homozygous LeuLeu genotype of codon 10 showed a slow progression of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11750277     DOI: 10.1016/s0009-8981(01)00738-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  21 in total

Review 1.  Genome-wide association studies and genetic risk assessment of liver diseases.

Authors:  Marcin Krawczyk; Roman Müllenbach; Susanne N Weber; Vincent Zimmer; Frank Lammert
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

2.  Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis.

Authors:  Hongxia Jia; Lili Yu; Bin Gao; Qiuhe Ji
Journal:  Endocrine       Date:  2011-07-02       Impact factor: 3.633

3.  Transforming growth factor beta1 gene variation Leu10Pro affects secretion and function in hepatic cells.

Authors:  Xing Gu; Xin Ji; Le-Hua Shi; Chang-Hong Yi; Yun-Peng Zhao; Ai-Hua Wang; Lun-Gen Lu; Wen-Bo Yu; Chun-Fang Gao
Journal:  Dig Dis Sci       Date:  2012-05-22       Impact factor: 3.199

4.  Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.

Authors:  Hao Wang; Senait Mengsteab; Carmen-G Tag; Chun-Fang Gao; Claus Hellerbrand; Frank Lammert; Axel-M Gressner; Ralf Weiskirchen
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 5.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

6.  TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Fang Fang; Long Yu; Yang Zhong; Lei Yao
Journal:  Med Oncol       Date:  2009-12-10       Impact factor: 3.064

7.  Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers.

Authors:  Sang Kyun Yu; Oh Sang Kwon; Hyuk Sang Jung; Kyung Suk Bae; Kwang An Kwon; Yu Kyung Kim; Yun Soo Kim; Ju Hyun Kim
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

8.  Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.

Authors:  Mariano Berro; Neema P Mayor; Hazael Maldonado-Torres; Louise Cooke; Gustavo Kusminsky; Steven G E Marsh; J Alejandro Madrigal; Bronwen E Shaw
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

9.  Transforming growth factor beta1 (TGFβ1) polymorphisms and breast cancer risk.

Authors:  Davar Amani; Ahad Khalilnezhad; Abbas Ghaderi; Norrio Niikawa; Ko-ichiro Yoshiura
Journal:  Tumour Biol       Date:  2014-01-15

10.  Role of host genetics in fibrosis.

Authors:  Georgina L Hold; Paraskevi Untiveros; Karin A Saunders; Emad M El-Omar
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.